MEDICA 2025 is just around the corner!

We’re excited to be back at MEDICA 2025 and can’t wait to catch up with partners, customers, and colleagues from around the world.Together with our sister company IVD TRIALS, we’re ready to share our expertise and support you in your next project. BIOMEX stands for high-quality human biospecimens for research and diagnostics, while IVD TRIALS Read More

BIOMEX at the EMBO | EMBL Symposium 2025

We are excited to announce that BIOMEX will be attending the EMBO | EMBL Symposium: Organoids – Modelling Organ Development and Disease in 3D, taking place from 22–25 October 2025 in Heidelberg. Visit us at booth F20 to connect with our expert and scientist Dr. Djeda Belharazem, who will be on-site to answer your questions Read More

BIOMEX at ADLM 2025

The countdown is on – ADLM 2025 is just around the corner, and we’re excited to be part of it once again. From July 29 to 31, you’ll find BIOMEX and IVD TRIALS joining forces at booth #4625 in Chicago. Last year at ADLM, we had some incredible conversations, made valuable connections, and kicked off Read More

EACR 2025 – A Strong Showing in Lisbon

Three inspiring days at EACR 2025 in Lisbon are behind us, and we’re excited about the impact this event had for us. It proved to be a well-focused platform to strengthen visibility and connect with key players in cancer research. Our colleague Adrien Lecocq represented us on-site and did an excellent job engaging with researchers, Read More

BIOMEX at EACR 2025

We are happy to announce that BIOMEX will be participating in the EACR2025 in Lisbon from 16 to 19 June. The annual congress of the European Association for Cancer Research is dedicated to basic research, preclinical research and translational cancer research and provides an important platform for scientific exchange and collaboration. We are happy to Read More

BIOMEX at the ASGCT 2025!

BIOMEX is excited to announce our first-ever presence at the ASGCT Annual Meeting – the American Society of Gene & Cell Therapy – taking place from May 13–17, 2025 in New Orleans, LA! Meet our experts Hannah Hill and Adrien Lecocq at Booth #1255 and discover how BIOMEX can support your work in Cell and Read More

CACLP 2025: Thank You for the Great Exchange!

We would like to extend our sincere thanks to all customers and interested visitors for the engaging conversations and valuable exchange during CACLP 2025, held from March 22 to 24. It was a pleasure to reconnect with familiar faces and to welcome new contacts at our booth. Throughout the event, we had numerous promising discussions, Read More

BIOMEX study team becomes IVD TRIALS GmbH!

Until December 31, 2024, the BIOMEX study team was an integral part of BIOMEX, delivering exceptional clinical IVD study services. As of January 1, 2025, our team transitioned to an independent company. It now operates under the name IVD TRIALS GmbH – allowing for greater flexibility, a stronger market position, and even more tailored services. Read More

Welcome to BIOMEX, Thomas Matthes!

We are excited to introduce Thomas Matthes as the new Director of the Life Sciences Business Unit at BIOMEX. With over 30 years of experience in the biotechnology, pharmaceutical, and diagnostics industries, he brings in-depth expertise in cell culture, stem cells, and personalized medicine. Thomas became aware of BIOMEX through LinkedIn, and the vision for Read More

Save the Date! Meet BIOMEX at CACLP 2025

We are excited to announce that BIOMEX will once again be part of CACLP 2025 in China! Are you looking for expert guidance on European IVDR requirements, support with regulatory validation studies, or high-quality biospecimens from a specialized German supplier? Our team is here to help. Where to find us? Visit us at Hall 7, Read More